Union City, CA, United States of America

Shaokang Zhang

USPTO Granted Patents = 2 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Shaokang Zhang in Pathogen Detection

Introduction

Shaokang Zhang is an accomplished inventor based in Union City, CA. He has made significant contributions to the field of pathogen detection, particularly through his innovative work in next-generation sequencing technologies. With a total of 2 patents, his inventions are paving the way for advancements in medical diagnostics.

Latest Patents

Zhang's latest patents focus on systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens. These patents provide fully-automated next-generation sequencing platforms designed for the detection of target specimens, such as SARS-CoV-2. The technology enables the differentiation between infectious and non-infectious signals from the specimen. This analysis can facilitate simultaneous diagnosis and genomic surveillance of multiple distinct specimens within a sample. Furthermore, it offers recommendations regarding the infectious status of the sample, thereby enhancing the understanding of infectivity in subjects or locations.

Career Highlights

Shaokang Zhang is currently employed at Clear Labs, Inc., where he continues to develop innovative solutions in the field of genomics. His work is instrumental in advancing the capabilities of pathogen detection and improving public health responses.

Collaborations

Zhang collaborates with notable colleagues, including Sasan Amini and Ramin Khaksar, who contribute to the innovative environment at Clear Labs, Inc.

Conclusion

Shaokang Zhang's contributions to pathogen detection through his patented technologies are vital for enhancing diagnostic capabilities in healthcare. His work exemplifies the importance of innovation in addressing public health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…